var digesttext = "FDA Grants Fast Track Designation To Tioga Pharmaceuticals\' Asimadoline For The Treatment Of Diarrhea-Predominant Irritable Bowel Syndrome (Jun 2, 2011 07:00)
Tioga Pharmaceuticals, Inc. announced that its investigational compound asimadoline has been granted..
That Anxiety May Be In Your Gut, Not In Your Head (May 17, 2011 15:00)
For the first time, researchers at McMaster University have conclusive evidence that bacteria residi..
Study Suggests Digestive Problems Early In Life May Increase Risk For Depression (May 13, 2011 08:00)
Depression and anxiety may result from short-term digestive irritation early in life, according ..
Cedars-Sinai Research Deepens Understanding Of Most Common Gastrointestinal Disorder In U.S., Linking It To Bacterial Overgrowth, Food Poisoning (May 11, 2011 08:00)
Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Synd..
2011 Digestive Disease Week: UNC Research Highlights (May 10, 2011 12:00)
Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and a..
Scientists Unmask Mysterious Cells As Key \'Border Patrol Agents\' In The Intestine (May 10, 2011 07:00)
Researchers at UT Southwestern Medical Center have uncovered new clues about how the intestine maint..
Ironwood And Forest To Present Linaclotide Results From Phase 3 Trials In Patients With Irritable Bowel Syndrome With Constipation (May 5, 2011 12:00)
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) today announ..
C. Difficile Increases Risk Of Death Sixfold In Patients With Inflammatory Bowel Disease (Apr 20, 2011 07:00)
Patients admitted to hospital with inflammatory bowel disease (IBD) face a sixfold greater risk of d..
Peppermint Earns Respect In Mainstream Medicine (Apr 19, 2011 14:00)
University of Adelaide researchers have shown for the first time how peppermint helps to relieve Irr..
Salix Receives Anticipated FDA Complete Response Letter On XIFAXAN(R) 550 Mg Tablets Non-C IBS Supplemental New Drug Application (Mar 11, 2011 09:00)
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the U.S. Food and Drug Administration (FDA)..
";
document.write(digesttext);